Charles Sizemore

Charles Sizemore

Charles Lewis Sizemore is a market veteran of 20-plus years, dedicated to helping people achieve financial freedom through smart investing.

He holds a Master’s Degree in Finance and Accounting from the London School of Economics and a Bachelor of Business Administration in Finance with an International Emphasis from Texas Christian University in Fort Worth, Texas, where he graduated Magna Cum Laude and as a Phi Beta Kappa scholar.

As a keen market observer, economist, investment analyst, and prolific writer, Charles has been a repeat guest on Fox Business, has been quoted in Barron’s Magazine, and has been featured in numerous well-reputed publications and financial websites, including MarketWatch, TheStreet.com, MSN Money, Seeking Alpha, Stocks, Futures, and Options magazine, The Daily Reckoning, Benzinga, Minyanville, and Investment International.

While Charles enjoys playing basketball and his grandfather’s old saxophone his passion lies in finding investment opportunities that become safe havens for investors navigating this age of chaos.

Learn more about Charles and The Freeport Society’s premium services.

Recent Articles

Review: The Little Book of Market Myths

Ken Fisher's Little Book of Market Myths is a great deconstruction of ineffective market aphorisms. If you want the truth about investing, pick it up.

TUR: Is it Time to Buy Turkish Stocks?

Turkish stocks are quickly reaching a "blood in the streets" buying opportunity. Put TUR on your watchlist, but don't buy just yet.

Intel Earnings: Hit or Miss, INTC Is a Buy

Analysts appear a little bearish heading into tomorrow's Intel earnings report, but long-term drivers point in favor of INTC stock.

AXP Earnings – Is American Express Optimism Overdone?

Will American Express surprise with better than expected earnings? Maybe, but AXP stock is still overpriced at current prices.

Can ‘Safer’ Cigarettes Save Tobacco Stocks?

Philip Morris is funneling $680 million into a factory for "safer" cigarettes, but I'm not buying the potential for tobacco stocks in such less-lethal efforts.